Physicochemical Properties
| Molecular Formula | C20H41N5O7.XH2SO4 |
| Molecular Weight | 561.64732 |
| Exact Mass | 561.268 |
| CAS # | 66803-19-8 |
| Related CAS # | Micronomicin;52093-21-7 |
| PubChem CID | 171808 |
| Appearance | White to yellow solid powder |
| Density | 1.32g/cm3 |
| Boiling Point | 667.2ºC at 760mmHg |
| Flash Point | 357.3ºC |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 37 |
| Complexity | 688 |
| Defined Atom Stereocenter Count | 12 |
| SMILES | C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)CNC)N)N)N)O.OS(=O)(=O)O |
| InChi Key | MQDGQSCLOYLSEK-SCFBDNQUSA-N |
| InChi Code | InChI=1S/C20H41N5O7.H2O4S/c1-20(28)8-29-19(14(27)17(20)25-3)32-16-12(23)6-11(22)15(13(16)26)31-18-10(21)5-4-9(30-18)7-24-2;1-5(2,3)4/h9-19,24-28H,4-8,21-23H2,1-3H3;(H2,1,2,3,4)/t9-,10+,11-,12+,13-,14+,15+,16-,17+,18+,19+,20-;/m0./s1 |
| Chemical Name | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(methylaminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | Aminoglycoside |
| ln Vitro | Micronomicin exhibits strong antibacterial properties; it effectively combats Staphylococcus aureus FDA 209 P, exhibiting minimal inhibitory values of 0.01 μg/ml. Additionally, it is anti-Escherichia coli St. M. The minimal inhibitory values were 0.75 μg/ml, 0.3 μg/ml, 0.03 μg/ml, and 0.03 μg/ml for 589, Baker 2, F 14-BK, and R5/W677. Additionally, it exhibits activity against strains of Lebsiella pneumoniae and Pseudomonas aeruginosa (MICs = 0.03-17.5 μg/ml)[1]. |
| ln Vivo | Micronomicin sulfate has an intravenous acute LD50 of 93 mg/kg in mice and is very effective against a variety of bacterial infections in mice[1]. Subacute toxicity studies involve the intravenous injection of micronomicin sulfate at a dose of 4-100 mg/kg over a 30-day period. Ataxia and renal problems cause the wistar rats (10 out of 30 animals) to die at the 100 mg/kg dose. Renal histopathological abnormalities primarily manifest at dosages beyond 25 mg/kg [3]. |
| Animal Protocol |
Animal/Disease Models: Wistar rats[3] Doses: 4, 10, 25, 63 mg/kg and 100 mg/kg Route of Administration: intravenous (iv)injection; 30 days Experimental Results: Led to death of rat at 100 mg/kg. |
| References |
[1]. A New Antibiotic XK-62-2 (Sagamicin). I. Isolation, Physicochemical and Antibacterial Properties. J Antibiot (Tokyo). [2]. P J Daniels, The Gentamicin Antibiotics. 6. Gentamicin C2b, an Aminoglycoside Antibiotic Produced by Micromonospora Purpurea Mutant JI-33. J Antibiot (Tokyo). [3]. Safety Evaluation of Micronomicin V. Subacute Toxicity in Rats After Intravenous Injection. Jpn J Antibiot. 1983 Nov;36(11):3208-25. |
| Additional Infomation | Micronomicin sulfate is an aminoglycoside sulfate salt. It is functionally related to a micronomicin. |
Solubility Data
| Solubility (In Vitro) | H2O : 50 mg/mL |
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (Infinity mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.7805 mL | 8.9023 mL | 17.8047 mL | |
| 5 mM | 0.3561 mL | 1.7805 mL | 3.5609 mL | |
| 10 mM | 0.1780 mL | 0.8902 mL | 1.7805 mL |